Patents by Inventor PAUL MENDELMAN

PAUL MENDELMAN has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • PARENTERAL NOROVIRUS VACCINE FORMULATIONS
    Publication number: 20230338503
    Abstract: The present invention relates to single dose parenteral vaccine compositions comprising mixtures of monovalent Norovirus virus-like particles. Methods of conferring protective immunity against Norovirus infections in a human subject by administering such compositions are also disclosed.
    Type: Application
    Filed: May 24, 2023
    Publication date: October 26, 2023
    Inventors: Charles RICHARDSON, Thomas R. FOUBERT, Robert F. BARGATZE, Paul MENDELMAN
  • Parenteral norovirus vaccine formulations
    Patent number: 11701420
    Abstract: The present invention relates to single dose parenteral vaccine compositions comprising mixtures of monovalent Norovirus virus-like particles. Methods of conferring protective immunity against Norovirus infections in a human subject by administering such compositions are also disclosed.
    Type: Grant
    Filed: June 5, 2020
    Date of Patent: July 18, 2023
    Assignee: Takeda Vaccines, Inc.
    Inventors: Charles Richardson, Thomas R. Foubert, Robert F. Bargatze, Paul Mendelman
  • NOROVIRUS VACCINE FORMULATIONS AND METHODS
    Publication number: 20220054621
    Abstract: The invention is in the field of vaccines, particularly vaccines for Noroviruses. In addition, the invention relates to methods of preparing vaccine compositions and methods of inducing and evaluating protective immune responses against Norovirus in humans, in particular, pediatric patients.
    Type: Application
    Filed: December 20, 2019
    Publication date: February 24, 2022
    Inventors: Taisei MASUDA, James SHERWOOD, Paul MENDELMAN, Frank BAEHNER
  • PARENTERAL NOROVIRUS VACCINE FORMULATIONS
    Publication number: 20210085778
    Abstract: The present invention relates to single dose parenteral vaccine compositions comprising mixtures of monovalent Norovirus virus-like particles. Methods of conferring protective immunity against Norovirus infections in a human subject by administering such compositions are also disclosed.
    Type: Application
    Filed: June 5, 2020
    Publication date: March 25, 2021
    Inventors: CHARLES RICHARDSON, THOMAS S. FOUBERT, ROBERT F. BARGATZE, PAUL MENDELMAN